Parker C - Search Results

1

Prostate cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up.

Horwich A, Parker C, de Reijke T, Kataja V; ESMO Guidelines Working Group. Horwich A, et al. Among authors: parker c. Ann Oncol. 2013 Oct;24 Suppl 6:vi106-14. doi: 10.1093/annonc/mdt208. Epub 2013 Jun 27. Ann Oncol. 2013. PMID: 23813930 Free article. No abstract available.

2

The management of PSA failure after radical radiotherapy for localized prostate cancer.

Parker CC, Dearnaley DP. Parker CC, et al. Radiother Oncol. 1998 Nov;49(2):103-10. doi: 10.1016/s0167-8140(98)00107-8. Radiother Oncol. 1998. PMID: 10052875 Review.

3

Pre-treatment nomogram for biochemical control after neoadjuvant androgen deprivation and radical radiotherapy for clinically localised prostate cancer.

Parker CC, Norman AR, Huddart RA, Horwich A, Dearnaley DP. Parker CC, et al. Br J Cancer. 2002 Mar 4;86(5):686-91. doi: 10.1038/sj.bjc.6600160. Br J Cancer. 2002. PMID: 11875726 Free PMC article. Clinical Trial.

4

Management of early prostate cancer.

Horwich A, Parker CC, Huddart RA, Dearnaley DP. Horwich A, et al. Among authors: parker cc. Ann Oncol. 2002;13 Suppl 4:83-7. doi: 10.1093/annonc/mdf643. Ann Oncol. 2002. PMID: 12401671 Free article. Review. No abstract available.

5

Active surveillance: an individualized approach to early prostate cancer.

Parker C. Parker C. BJU Int. 2003 Jul;92(1):2-3. doi: 10.1046/j.1464-410x.2003.04295.x. BJU Int. 2003. PMID: 12823371 No abstract available.

6

The role of hemoglobin concentration in clinically localized prostate cancer treated with radical radiotherapy +/- neoadjuvant androgen deprivation.

Parker C, Warde P, Norman A, Panzarella T, Catton C, Horwich A, Huddart R, Dearnaley D. Parker C, et al. Int J Radiat Oncol Biol Phys. 2004 Jan 1;58(1):53-8. doi: 10.1016/s0360-3016(03)00821-6. Int J Radiat Oncol Biol Phys. 2004. PMID: 14697420

7

Current opinion on adjuvant and salvage treatment after radical prostatectomy.

Morris SL, Parker C, Huddart R, Horwich A, Dearnaley D. Morris SL, et al. Among authors: parker c. Clin Oncol (R Coll Radiol). 2004 Jun;16(4):277-82. doi: 10.1016/j.clon.2004.03.004. Clin Oncol (R Coll Radiol). 2004. PMID: 15214652

8

Early outcomes of active surveillance for localized prostate cancer.

Hardie C, Parker C, Norman A, Eeles R, Horwich A, Huddart R, Dearnaley D. Hardie C, et al. Among authors: parker c. BJU Int. 2005 May;95(7):956-60. doi: 10.1111/j.1464-410X.2005.05446.x. BJU Int. 2005. PMID: 15839912

9

Tumour staging using magnetic resonance imaging in clinically localised prostate cancer: relationship to biochemical outcome after neo-adjuvant androgen deprivation and radical radiotherapy.

Jackson AS, Parker CC, Norman AR, Padhani AR, Huddart RA, Horwich A, Husband JE, Dearnaley DP. Jackson AS, et al. Among authors: parker cc. Clin Oncol (R Coll Radiol). 2005 May;17(3):167-71. doi: 10.1016/j.clon.2004.08.007. Clin Oncol (R Coll Radiol). 2005. PMID: 15901000

10

The utility of digital rectal examination after radical radiotherapy for prostate cancer.

Doneux A, Parker CC, Norman A, Eeles R, Howich A, Huddart R, Dearnaley D. Doneux A, et al. Among authors: parker cc. Clin Oncol (R Coll Radiol). 2005 May;17(3):172-3. doi: 10.1016/j.clon.2004.10.009. Clin Oncol (R Coll Radiol). 2005. PMID: 15901001

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

3,173 results

Search Page

Filters